| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer
1 company
Aromando Andrew is a Chief Business Officer at ONCOLYTICS BIOTECH INC. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $53K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | ONCY Oncolytics Biotech Inc | Chief Business Officer | Buy | 29,600 | $0.86 | $25,417.52 | +116.1% | +5.4% | - |